S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
18.47
+1.79
+10.73%
GEL · Genesis Energy, L.P.
NEW YORK STOCK EXCHANGE, INC. - Real Time Price • USD
$14.06
-0.03
(-0.21%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$14.06
$13.98
$14.20
52-WEEK RANGE
$14.06
$13.55
$18.64
What's happening
- GEL is down 0.21% today, trading at $14.06. — Live quote
- Volume today (17,390) is well below its 3-month average of 294,790. (Finnhub fundamentals)
- Reports earnings on 2026-11-05, 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $0.12 actual vs. $0.02 estimated (+494.1%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 1
Buy 5
Hold 1
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (7 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
GEL
-10.06%
vs S&P 500
-23.43%
1-YEAR RETURN
GEL
-8.78%
vs S&P 500
-23.94%
6-MONTH RETURN
GEL
-16.64%
3-MONTH RETURN
GEL
-6.15%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$0.12
Est. $0.02
BEAT +494.1%
2026-04-26 (Q1 2026)
$-0.06
Est. $0.16
MISS -137.1%
2026-01-26 (Q4 2025)
$0.04
Est. $0.28
MISS -85.9%
2025-10-26 (Q3 2025)
$-0.05
Est. $0.13
MISS -138.1%
Valuation Measures & Ratios
Enterprise Value4$5.21B
Forward P/E5308.43
PEG Ratio6—
Price / Sales (TTM1)1.33
Price / Book74.28
EV4 / Revenue4.04
EV4 / EBITDA8.85
Profit Margin0.63%
Operating Margin1.65%
Return on Equity (ROE8)-15.94%
Return on Assets (ROA9)1.58%
Avg Volume (3M)294,790
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $2.31B | — | — | $55.3M | $1.70B |
| P/E | 39.50 | — | — | -0.11 | -3.51 |
| Price/Sales | 1.30 | — | — | 0.03 | 1.02 |
| EV/Revenue | 3.09 | — | — | 1.97 | 2.87 |
| EV/EBITDA | 9.72 | — | — | — | — |
| ROA | 1.08% | — | — | -10.24% | -9.28% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short2,517,473
Change from Prior Settlement-0.41%
% of Float—
Days to Cover (Short Ratio)7.31
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 30.3% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-10-02; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is 0.6%. Finnhub fundamentals ↗
- Trailing 52-week price return is -8.8%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on GEL
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $532.0M | $446.6M | $414.0M | $377.3M | $398.3M | $397.3M | $430.2M | $434.4M |
| Operating income | $105.4M | $76.6M | $78.6M | $67.7M | $22.0M | $48.6M | $49.8M | $58.1M |
| Net income | $42.9M | $6.8M | $9.2M | -$406.0K | -$469.1M | -$17.2M | -$8.7M | $11.4M |
| EPS (diluted) | $0.26 | $-0.06 | $-0.05 | $-0.12 | $-4.06 | $-0.32 | $-0.25 | $-0.09 |
| EPS (basic) | $0.26 | $-0.06 | $-0.05 | $-0.12 | $-4.06 | $-0.32 | $-0.25 | $-0.09 |
| Operating margin | $20 | $17 | $19 | $18 | $6 | $12 | $12 | $13 |
| Net margin | $8 | $2 | $2 | -$0 | -$118 | -$4 | -$2 | $3 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $5.41B | $4.84B | $4.86B | $4.87B | $4.84B | $5.21B | $7.04B | $7.06B |
| Total liabilities | $4.96B | $4.30B | $4.15B | $4.16B | $4.12B | $4.47B | $5.52B | $5.46B |
| Total current assets | $1.30B | $702.8M | $687.5M | $652.0M | $587.3M | $937.3M | $911.7M | $925.3M |
| Total current liabilities | $1.40B | $720.7M | $699.7M | $673.2M | $621.9M | $633.0M | $858.8M | $897.0M |
| Cash & equivalents | $39.3M | $4.2M | $6.4M | $4.9M | $4.5M | $377.4M | $7.4M | $13.0M |
| Accounts receivable | $1.19B | $628.6M | $608.2M | $577.5M | $499.6M | $498.2M | $479.5M | $745.6M |
| Inventory | $38.6M | $39.2M | $55.4M | $49.2M | $58.2M | $38.1M | $37.8M | $110.7M |
| Other current assets | $27.1M | $30.8M | $17.4M | $20.3M | $25.1M | $23.7M | $18.8M | $37.3M |
| Property, plant & equipment | $3.40B | $3.43B | $3.47B | $3.50B | $3.53B | $3.54B | $3.54B | $4.63B |
| Goodwill | $302.0M | $302.0M | $302.0M | $302.0M | $302.0M | $302.0M | $302.0M | $302.0M |
| Intangible assets | $71.0M | $73.3M | $75.6M | $78.0M | $80.4M | $82.9M | $85.3M | $142.1M |
| Other non-current assets | $59.1M | $54.8M | $54.0M | $55.1M | $55.9M | $55.0M | $53.6M | $49.2M |
| Accounts payable | $1.10B | $508.3M | $490.7M | $448.7M | $414.4M | $401.9M | $388.2M | $539.0M |
| Accrued liabilities | $203.0M | $212.4M | $209.0M | $224.6M | $207.5M | $231.1M | $254.2M | $358.1M |
| Deferred revenue (current) | $43.9M | $29.6M | $27.0M | $30.0M | $33.4M | $38.0M | $41.6M | $38.6M |
| Short-term debt | $99.5M | — | $0 | — | — | — | — | — |
| Long-term debt | $3.10B | $3.18B | $3.05B | $3.10B | $3.11B | $3.44B | $3.73B | $4.02B |
| Other non-current liabilities | $439.5M | $387.1M | $388.7M | $374.8M | $374.9M | $382.9M | $389.2M | $541.9M |
| Accumulated other comprehensive income (loss) | — | — | $0 | $0 | $0 | $0 | $9.5M | $8.3M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $180.7M | $81.7M | $110.8M | $70.3M | $47.0M | $24.8M | $74.0M | $87.3M |
| Investing cash flow | -$22.0M | -$23.1M | -$19.6M | -$21.3M | -$48.2M | $921.3M | -$115.8M | -$112.3M |
| Financing cash flow | -$118.7M | -$60.8M | -$89.7M | -$48.5M | -$371.7M | -$598.3M | $39.6M | $24.3M |
| Depreciation & amortization | $63.1M | $58.9M | $62.9M | $57.1M | $55.9M | $75.0M | $79.9M | $81.8M |
| Share-based compensation | $2.9M | -$137.0K | $5.4M | $4.2M | $3.2M | $2.5M | -$2.9M | -$1.7M |
| Deferred income taxes | -$91.0K | -$188.0K | $688.0K | -$47.0K | $45.0K | -$113.0K | $1.9M | -$1.2M |
| Change in accounts receivable | $561.9M | $20.0M | $29.6M | $78.1M | $8.6M | $4.5M | -$3.0M | $58.6M |
| Change in inventory | -$635.0K | -$16.9M | $6.1M | -$9.4M | $20.5M | $5.8M | $254.0K | $1.7M |
| Change in accounts payable | $588.3M | $5.8M | $48.9M | $37.8M | $18.6M | -$744.0K | -$31.3M | $100.0M |
| Other investing activities | — | — | $0 | — | — | — | $0 | $0 |
| Share repurchases | $3.6M | — | $0 | — | $0 | — | $0 | $0 |
| Debt issued | — | — | — | — | — | — | — | — |
| Other financing activities | -$2.4M | $9.0M | -$3.1M | -$3.5M | -$3.3M | $7.2M | -$4.6M | $215.0K |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $1.63B | $1.66B | $1.72B | $2.79B | $2.13B |
| Operating income | $258.2M | $170.0M | $205.1M | $315.0M | $75.7M |
| Net income | -$440.4M | -$63.9M | $117.7M | $75.5M | -$165.1M |
| EPS (diluted) | $-4.19 | $-1.24 | $0.22 | $-0.04 | $-1.96 |
| EPS (basic) | $-4.19 | $-1.24 | $0.22 | $-0.04 | $-1.96 |
| Operating margin | $16 | $10 | $12 | $11 | $4 |
| Net margin | -$27 | -$4 | $7 | $3 | -$8 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $4.86B | $7.04B | $7.02B | $6.37B | $5.91B |
| Total liabilities | $4.15B | $5.52B | $5.31B | $4.59B | $3.93B |
| Total current assets | $687.5M | $911.7M | $964.0M | $853.0M | $542.5M |
| Total current liabilities | $699.7M | $858.8M | $967.4M | $709.1M | $496.9M |
| Cash & equivalents | $6.4M | $7.4M | $9.2M | $7.9M | $20.0M |
| Accounts receivable | $608.2M | $479.5M | $759.5M | $721.6M | $400.3M |
| Inventory | $55.4M | $37.8M | $135.2M | $78.1M | $78.0M |
| Other current assets | $17.4M | $18.8M | $41.2M | $26.8M | $39.2M |
| Property, plant & equipment | $3.47B | $3.54B | $4.53B | $4.10B | $3.91B |
| Goodwill | $302.0M | $302.0M | $302.0M | $302.0M | $302.0M |
| Intangible assets | $75.6M | $85.3M | $141.5M | $127.3M | $127.1M |
| Other non-current assets | $54.0M | $53.6M | $38.2M | $32.2M | $38.3M |
| Accounts payable | $490.7M | $388.2M | $588.9M | $428.0M | $264.3M |
| Accrued liabilities | $209.0M | $254.2M | $378.5M | $281.1M | $232.6M |
| Deferred revenue (current) | $27.0M | $41.6M | $11.5M | $2.1M | $2.6M |
| Long-term debt | $3.05B | $3.73B | $3.76B | $3.46B | $2.98B |
| Other non-current liabilities | $388.7M | $389.2M | $570.2M | $400.6M | $434.9M |
| Accumulated other comprehensive income (loss) | $0 | $9.5M | $8.0M | $6.1M | -$5.6M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $252.8M | $391.9M | $521.1M | $334.4M | $338.0M |
| Investing cash flow | $832.3M | -$552.2M | -$593.6M | -$374.5M | -$274.1M |
| Financing cash flow | -$1.11B | $161.7M | $74.0M | $41.7M | -$65.9M |
| Depreciation & amortization | $250.9M | $313.2M | $280.2M | $296.2M | $309.7M |
| Share-based compensation | $15.3M | $5.2M | $25.4M | $17.8M | $8.8M |
| Deferred income taxes | $573.0K | $749.0K | -$380.0K | $2.4M | $980.0K |
| Change in accounts receivable | $120.9M | -$17.5M | -$159.4M | $261.8M | $75.2M |
| Change in inventory | $23.0M | -$38.8M | $37.6M | -$2.1M | -$20.4M |
| Change in accounts payable | $104.7M | $434.0K | -$135.3M | $152.1M | $44.1M |
| Other investing activities | $0 | $0 | -$4.3M | $0 | $0 |
| Share repurchases | $0 | $0 | $1.0M | $0 | $0 |
| Other financing activities | -$2.8M | -$1.1M | $904.0K | $1.5M | -$84.0K |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding GEL as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-04-01 to 2026-10-01
Recent transactions
- Insiders have net bought 12,340 shares over the last 182 days, across 1 purchase and 0 sales.
- Most recent: GASAWAY SHARILYN S (Director) — Option exercise of 2,533 shares on 2026-10-01.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)12,340 sh(1 txns)
Sales (open market)0 sh(0 txns)
Net Shares+12,340
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| GASAWAY SHARILYN S | Director | Option exercise | 2026-10-01 | 2,533 |
| ALBERT CONRAD P | Director | Option exercise | 2026-10-01 | 2,533 |
| Taylor Jack T | Director | Option exercise | 2026-10-01 | 2,609 |
| Davison James E. Jr. | Director | Option exercise | 2026-10-01 | 2,420 |
| JASTROW KENNETH M II | Director | Option exercise | 2026-10-01 | 2,685 |
| Gaspard Garland G | Senior Vice President | Open market purchase | 2026-05-18 | 12,340 |
| Davison James E | Director | Option exercise | 2026-04-01 | 2,372 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-01 | GASAWAY SHARILYN S | Director | Option exercise | 2,533 | — |
| 2026-10-01 | GASAWAY SHARILYN S | Director | Disposition to issuer | 2,533 | $15.08 |
| 2026-10-01 | ALBERT CONRAD P | Director | Option exercise | 2,533 | — |
| 2026-10-01 | ALBERT CONRAD P | Director | Disposition to issuer | 2,533 | $15.08 |
| 2026-10-01 | Taylor Jack T | Director | Option exercise | 2,609 | — |
| 2026-10-01 | Taylor Jack T | Director | Disposition to issuer | 2,609 | $15.08 |
| 2026-10-01 | Davison James E. Jr. | Director | Option exercise | 2,420 | — |
| 2026-10-01 | Davison James E. Jr. | Director | Disposition to issuer | 2,420 | $15.08 |
| 2026-10-01 | JASTROW KENNETH M II | Director | Option exercise | 2,685 | — |
| 2026-10-01 | JASTROW KENNETH M II | Director | Disposition to issuer | 2,685 | $15.08 |
| 2026-07-01 | ALBERT CONRAD P | Director | Option exercise | 2,500 | — |
| 2026-07-01 | ALBERT CONRAD P | Director | Disposition to issuer | 2,500 | $14.77 |
| 2026-07-01 | Taylor Jack T | Director | Option exercise | 2,575 | — |
| 2026-07-01 | Taylor Jack T | Director | Disposition to issuer | 2,575 | $14.77 |
| 2026-07-01 | Davison James E. Jr. | Director | Option exercise | 2,388 | — |
| 2026-07-01 | Davison James E. Jr. | Director | Disposition to issuer | 2,388 | $14.77 |
| 2026-07-01 | JASTROW KENNETH M II | Director | Option exercise | 2,649 | — |
| 2026-07-01 | JASTROW KENNETH M II | Director | Disposition to issuer | 2,649 | $14.77 |
| 2026-07-01 | GASAWAY SHARILYN S | Director | Option exercise | 2,500 | — |
| 2026-07-01 | GASAWAY SHARILYN S | Director | Disposition to issuer | 2,500 | $14.77 |
| 2026-05-21 | Davison James E. Jr. | Director | Other acquisition/disposition | 1,527,239 | — |
| 2026-05-18 | Gaspard Garland G | Senior Vice President | Open market purchase | 12,340 | $16.34 |
| 2026-04-01 | ALBERT CONRAD P | Director | Option exercise | 2,491 | — |
| 2026-04-01 | ALBERT CONRAD P | Director | Disposition to issuer | 2,491 | $17.88 |
| 2026-04-01 | JASTROW KENNETH M II | Director | Option exercise | 2,570 | — |
| 2026-04-01 | JASTROW KENNETH M II | Director | Disposition to issuer | 2,570 | $17.88 |
| 2026-04-01 | Davison James E. Jr. | Director | Option exercise | 2,372 | — |
| 2026-04-01 | Davison James E. Jr. | Director | Disposition to issuer | 2,372 | $17.88 |
| 2026-04-01 | Davison James E | Director | Option exercise | 2,372 | — |
| 2026-04-01 | Davison James E | Director | Disposition to issuer | 2,372 | $17.88 |
| 2026-04-01 | Taylor Jack T | Director | Option exercise | 2,570 | — |
| 2026-04-01 | Taylor Jack T | Director | Disposition to issuer | 2,570 | $17.88 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 08:39 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-02 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-02 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-02 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-02 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-02 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-08-06 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-06 | 8-K | 2026-08-06 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-07-01 | View on SEC.gov → |
Recent news
Headlines about GEL (Genesis Energy, L.P.). Links open the publisher — we don’t host full articles.
-
Recce Pharmaceuticals Signs Exclusive Deal with Arrotex for 327 Topical Gel
Small Caps · 2026-10-21 -
Total common shares outstanding of GELEX Infrastructure Joint Stock Company – HOSE:GEL
TradingView · 2026-10-20 -
Cosmo (SWX:CMHC) Posted Positive Phase 2 Results For Rifamycin Gel
Yahoo Finance · 2026-10-20 -
Inflation-Resistant Income Growth Machines Getting Too Cheap
SeekingAlpha · 2026-10-19 -
Why Is Cosmo (SWX:CMHC) Advancing Rifamycin Gel After Its Phase 2 Success?
Simply Wall Street · 2026-10-19 -
2 of Wall Street’s Favorite Stocks with Impressive Fundamentals and 1 We Ignore
Yahoo · 2026-10-19 -
HC Wainwright & Co. reiterates Buy rating on Sol-Gel Technologies, $110 price target
TradingView · 2026-10-19 -
Asics Gel-Kayano 20 "Black" T3N2N-9001
SNKRDUNK · 2026-10-19
No headlines in this category right now — try “All”.